The acid-labile subunit is required for full effects of exogenous growth hormone on growth and carbohydrate metabolism

Endocrinology

Volumn 150, Issue 7, 2009, Pages 3145-3152

  Ueki, Iori ^a   Giesy, Sarah L ^a   Harvatine, Kevin J ^a   Jin, Wook Kim ^b   Boisclair, Yves R ^a,c  

^a Department of Obstetrics Gynecology   (United States)

^b Gyeongsang National University   (South Korea)

^c 259 Morrison Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SODIUM CHLORIDE; SOMATOMEDIN C;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; COW; DNA MODIFICATION; FEMALE; GROWTH; HORMONE RESPONSE; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; WEIGHT GAIN; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; FEMALE; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MUSCLE, SKELETAL; WEIGHT GAIN;

EID: 67649669260     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1740     Document Type: Article

References (48)

1. Efstratiadis A 1998 Genetics of mouse growth. Int J Dev Biol 42:955-976 (Pubitemid 28530752)
2. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162 (Pubitemid 32061720)
3. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82 (Pubitemid 23306022)
4. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220 (Pubitemid 27518502)
5. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144 (Pubitemid 24336141)
6. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74 (Pubitemid 32187803)
7. Boisclair YR, Rhoads RP, Ueki I,WangJ, OoiGT2001 The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 170:63-70 (Pubitemid 32677567)
8. D'Ercole AJ, Stiles AD, Underwood LE 1984 Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 81:935-939 (Pubitemid 14197617)
9. Murphy LJ, Bell GI, Duckworth ML, Friesen HG 1987 Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology 121:684-691 (Pubitemid 17102014)
10. Rechler MM 1993 Insulin-like growth factor binding proteins. Vitam Horm 47: 1-114
11. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329 (Pubitemid 29299660)
12. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, Boisclair YR 2000 Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci USA 97:6868-6873 (Pubitemid 30412806)
13. Yakar S, Rosen CJ, Bouxsein ML, Sun H, Mejia W, Kawashima Y, Wu Y, Emerton K, Williams V, Jepsen K, Schaffler MB, Majeska RJ, Gavrilova O, Gutierrez M, Hwang D, Pennisi P, Frystyk J, Boisclair Y, Pintar J, Jasper H, Domene H, Cohen P, Clemmons D, LeRoith D 2008 Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. FASEB J 23:709-719
14. Wu Y, Sun H, Kawashima Y, Yakar S, LeRoith D, Liver-derived, circulating (endocrine) insulin-like growth factor-1, is sufficient to support normal postnatal growth. Program of the 90th Annual Meeting of The Endocrine Society, San Francisco, CA, 2008, p 103 (Abstract OR15-1)
15. Bichell DP, Kikuchi K, Rotwein P 1992Growthhormonerapidly activates insulinlike growth factor I gene transcription in vivo. Mol Endocrinol 6:1899-1908
16. Thissen J-P, Ketelslegers J-M, Underwood LE 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101 (Pubitemid 24058597)
17. Phillips LS, Pao CI, Villafuerte BC 1998 Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acids Res Mol Biol 60:195-265
18. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781 (Pubitemid 35050954)
19. Govoni KE, Lee SK, Chung YS, Behringer RR, Wergedal JE, Baylink DJ, Mohan S 2007 Disruption of insulin-like growth factor-I expression in type IIαI collagen-expressing cells reduces bone length and width in mice. Physiol Genomics 30:354-362 (Pubitemid 47296194)
20. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
21. Hwang DL, Lee PD, Cohen P 2008 Quantitative ontogeny of murine insulinlike growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acidlabile subunit. Growth Horm IGF Res 18:65-74
22. Mathews LS, Norstedt G, Palmiter RD 1986 Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 83:9343-9347 (Pubitemid 17223357)
23. Kikuchi K, Bichell DP, Rotwein P 1992 Chromatin changes accompany the developmental activation of insulin-like growth factor I gene transcription. J Biol Chem 267:21505-21511
24. Tiong TS, Herington AC 1992 Ontogeny of messenger RNA for the rat growth hormone receptor and serum binding protein. Mol Cell Endocrinol 83:133-141
25. Dai J, Baxter RC 1994 Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 135:2335-2341 (Pubitemid 24377385)
26. Guler H-P, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenhagen) 121:753-758
27. Zapf J, Hauri C, Futo E, Hussain M, Rutishauser J, Maack CA, Froesch ER 1995 Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 95:179-186
28. Postic C, Dentin R, Girard J 2004 Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30:398-408 (Pubitemid 39648006)
29. Kasukawa Y, Baylink DJ, Guo R, Mohan S 2003 Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice. Endocrinology 144:3950-3957 (Pubitemid 37088750)
30. Liu JL, LeRoith D 1999 Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140:5178-5184 (Pubitemid 30687128)
31. Etherton TD, Bauman DE 1998 Biology of somatotropin in growth and lactation of domestic animals. Physiol Rev 78:745-761 (Pubitemid 28340602)
32. Arquier N, Géminard C, Bourouis M, Jarretou G, Honegger B, Paix A, Léopold P 2008 Drosophila ALS regulates growth and metabolism through functional interaction with insulin-like peptides. Cell Metab 7:333-338
33. Fielder P, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG 1996 Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 137:1913-1920 (Pubitemid 26133968)
34. Liu JL, Yakar S, LeRoith D 2000 Mice deficient in liver production of insulinlike growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth. Endocrinology 141:4436-4441 (Pubitemid 32055118)
35. Yakar S, Liu JL, Fernandez AM,WuY, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D 2001 Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118 (Pubitemid 32374542)
36. Clemmons DR 2006 Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 6:620-625 (Pubitemid 44752640)
37. Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S 2007 Conditional deletion of insulin-like growth factor-I in collagen type 1α2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. Endocrinology 148:5706-5715 (Pubitemid 350146154)
38. Klover P, Hennighausen L 2007 Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology 148:1489-1497 (Pubitemid 46457107)
39. Liao L, Dearth RK, Zhou S, Britton OL, Lee AV, Xu J 2006 Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147:3877-3888 (Pubitemid 44079393)
40. HaluzikM,Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoithD2003 Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 52:2483-2489 (Pubitemid 37210535)
41. Baxter RC, Dai J 1994 Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 134:848-852 (Pubitemid 24057232)
42. Clemmons DR 2004 The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 113:25-27 (Pubitemid 38541628)
43. LeRoith D, Yakar S 2007 Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3:302-310 (Pubitemid 46310535)
44. Heath KE, Argente J, Barrios V, Pozo J, Díaz-Gonzá lez F, Martos-Moreno GA, Caimari M, Gracia R, Campos-Barros A 2008 Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia. J Clin Endocrinol Metab 93:1616-1624
45. Domené HM,Scaglia PA, Lteif A,MahmudFH, Kirmani S, Frystyk J, Bedecarrás P, Gutierrez M, Jasper HG 2007 Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations. J Clin Endocrinol Metab 92:4444-4450 (Pubitemid 350074768)
46. Hwa V, Haeusler G, Pratt KL, Little BM, Frisch H, Koller D, Rosenfeld RG 2006 Total absence of functional acid labile subunit, resulting in severe insulinlike growth factor deficiency and moderate growth failure. J Clin Endocrinol Metab 91:1826-1831
47. Domené HM, Bengolea SV, Martínez AS, Ropelato MG, Pennisi P, Scaglia P, Heinrich JJ, Jasper HG 2004 Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N Engl J Med 350:570-577 (Pubitemid 38160787)
48. Domené HM,Martínez AS, Frystyk J, Bengolea SV, Ropelato MG, Scaglia PA, Chen JW, Heuck C, Wolthers OD, Heinrich JJ, Jasper HG 2007 Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency. Horm Res 67:243-249 (Pubitemid 46558887)